Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis
- PMID: 25992575
- PMCID: PMC4439045
- DOI: 10.1371/journal.pone.0126980
Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis
Abstract
Anaerobic bacteria have been identified in abundance in the airways of cystic fibrosis (CF) subjects. The impact their presence and abundance has on lung function and inflammation is unclear. The aim of this study was to investigate the relationship between the colony count of aerobic and anaerobic bacteria, lung clearance index (LCI), spirometry and C-Reactive Protein (CRP) in patients with CF. Sputum and blood were collected from CF patients at a single cross-sectional visit when clinically stable. Community composition and bacterial colony counts were analysed using extended aerobic and anaerobic culture. Patients completed spirometry and a multiple breath washout (MBW) test to obtain LCI. An inverse correlation between colony count of aerobic bacteria (n = 41, r = -0.35; p = 0.02), anaerobic bacteria (n = 41, r = -0.44, p = 0.004) and LCI was observed. There was an inverse correlation between colony count of anaerobic bacteria and CRP (n = 25, r = -0.44, p = 0.03) only. The results of this study demonstrate that a lower colony count of aerobic and anaerobic bacteria correlated with a worse LCI. A lower colony count of anaerobic bacteria also correlated with higher CRP levels. These results indicate that lower abundance of aerobic and anaerobic bacteria may reflect microbiota disruption and disease progression in the CF lung.
Conflict of interest statement
Figures
Similar articles
-
Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis.Thorax. 2011 Jul;66(7):579-84. doi: 10.1136/thx.2010.137281. Epub 2011 Jan 26. Thorax. 2011. PMID: 21270069
-
Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.Am J Respir Crit Care Med. 2008 May 1;177(9):995-1001. doi: 10.1164/rccm.200708-1151OC. Epub 2008 Feb 8. Am J Respir Crit Care Med. 2008. PMID: 18263800
-
Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.PLoS One. 2013 Apr 30;8(4):e62917. doi: 10.1371/journal.pone.0062917. Print 2013. PLoS One. 2013. PMID: 23646159 Free PMC article.
-
[Lung clearance index in cystic fibrosis].Rev Mal Respir. 2019 Mar;36(3):377-395. doi: 10.1016/j.rmr.2018.03.007. Epub 2019 Jan 25. Rev Mal Respir. 2019. PMID: 30686561 Review. French.
-
The role of anaerobic bacteria in the cystic fibrosis airway.Curr Opin Pulm Med. 2016 Nov;22(6):637-43. doi: 10.1097/MCP.0000000000000299. Curr Opin Pulm Med. 2016. PMID: 27455453 Review.
Cited by
-
Alteration of the Respiratory Microbiome in Hospitalized Patients with Asthma-COPD Overlap during and after an Exacerbation.J Clin Med. 2023 Mar 8;12(6):2118. doi: 10.3390/jcm12062118. J Clin Med. 2023. PMID: 36983122 Free PMC article.
-
Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis.Front Med (Lausanne). 2023 Jan 9;9:1082125. doi: 10.3389/fmed.2022.1082125. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698799 Free PMC article.
-
Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis.mSystems. 2022 Oct 26;7(5):e0036422. doi: 10.1128/msystems.00364-22. Epub 2022 Aug 24. mSystems. 2022. PMID: 36000724 Free PMC article.
-
Effect of invasive mechanical ventilation on the diversity of the pulmonary microbiota.Crit Care. 2022 Aug 22;26(1):252. doi: 10.1186/s13054-022-04126-6. Crit Care. 2022. PMID: 35996150 Free PMC article. Review.
-
Antibiotics Drive Expansion of Rare Pathogens in a Chronic Infection Microbiome Model.mSphere. 2022 Oct 26;7(5):e0031822. doi: 10.1128/msphere.00318-22. Epub 2022 Aug 16. mSphere. 2022. PMID: 35972133 Free PMC article.
References
-
- Downey DG, Martin SL, Dempster M, Moore JE, Keogan MT, Starcher B, et al. The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis. Pediatr Pulmonol. 2007;42: 216–220. - PubMed
-
- Tunney MM, Klem ER, Fodor AA, Gilpin DF, Moriarty TF, McGrath SJ, et al. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax. 2011;66: 579–584. 10.1136/thx.2010.137281 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
